共 50 条
- [21] Update on malignant mesothelioma - The Antinan/Hassan/Eisner et al article reviewed ONCOLOGY-NEW YORK, 2005, 19 (10): : 1313 - +
- [22] Adenocarcinoma of the esophagus: Risk factors and prevention - The Forastiere et al article reviewed ONCOLOGY-NEW YORK, 2000, 14 (04): : 518 - +
- [23] The REMS Publication Paradox The Jamali/Lemery/Ayalew et al Article Reviewed ONCOLOGY-NEW YORK, 2009, 23 (08): : 715 - 721
- [24] The Evolving World of Tumor Lysis Syndrome THE MUSLIMANI ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (04): : 378 - 380
- [25] The More Things Change, the More They Stay the Same THE MUSLIMANI ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (04): : 381 - 382
- [26] The Road to Romiplostim Approval and Beyond The Jamali/Lemery/Ayalew et al Article Reviewed ONCOLOGY-NEW YORK, 2009, 23 (08): : 709 - 715
- [27] Honing therapy for rectal cancer - The Willet/Duda/Czito et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (09): : 1065 - +
- [28] Intraoperative Radiotherapy for Breast Cancer: Deceptively Simple? THE ASH ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2013, 27 (02): : 122 - +
- [29] Innate Immune B Cells Gone Bad THE BETORNI ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (12): : 1149 - +
- [30] Anthracyclines survive targeted therapy - The Ning/He/Dagher et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (12): : 1516 - +